Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis

Shu Yang, Han Wu, Yanchun Li, Lixin Li, Jiaqing Xiang, Lin Kang, Guangyan Yang, Zhen Liang · 2023

Read Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis by Shu Yang, Han Wu, Yanchun Li, Lixin Li, Jiaqing Xiang, Lin Kang, Guangyan Yang, Zhen Liang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10716164.txt.

Description

Shu Yang and colleagues finger a sugar-burning enzyme as the switch that turns kidney scarring on, in this study from twenty twenty-three. Chronic kidney disease rewires tubule cells toward glycolysis, and the platelet form of phosphofructokinase, PFKP, is its rate limiter. In mice with a blocked ureter, forcing extra PFKP into tubules widened them, fed glycolysis, and spread fibrosis; silencing it did the opposite.

The upstream hand was the scarring signal TGF-beta, which docks a SMAD3-SP1 protein complex onto the PFKP gene to raise its output, confirmed in human tubule cells. A plant flavonoid, isorhamnetin, dialled the enzyme's elevation back and eased both glycolysis and fibrosis in the animals. The authors propose PFKP as a metabolic drug target for kidney fibrosis, a disease with few.

Catalog record

CREATORShu Yang, Han Wu, Yanchun Li, Lixin Li, Jiaqing Xiang, Lin Kang, Guangyan Yang, Zhen Liang
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10716164

Browse the full library · About the Tower of Babel